CLDX
Celldex Therapeutics Inc
$39.18
+6.18% (+$2.28)
Volume
1.00M
52W High
$45.14
52W Low
$22.10
Market Cap
$3.24B
Next Earnings Report
Last Reported
Aug 6, 2026 Beat
Actual: -$0.94
vs. Consensus: -$1.04
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q2 2026
Aug 6, 2026
1-Day:
+0.36%
5-Day:
+6.67%
Q1 2026
May 14, 2026
1-Day:
-3.42%
5-Day:
-7.09%
Q1 2026
May 8, 2026
5-Day:
-4.30%
Q1 2026
May 7, 2026
1-Day:
+1.95%
5-Day:
-3.96%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $75,000 | -97.7% | 100.0% | -10,000.0% | -$81.4M |
| Q2'25 | $730,000 | -70.8% | 100.0% | -8,747.5% | -$56.6M |
| Q1'25 | $695,000 | +345.5% | 100.0% | -9,027.2% | -$53.8M |
| Q4'24 | $1.2M | -71.6% | 30.3% | -4,768.3% | -$47.1M |
| Q3'24 | $3.2M | +110.4% | 100.0% | -1,633.5% | -$42.1M |
| Q2'24 | $2.5M | +832.1% | 68.1% | -1,854.2% | -$35.8M |
| Q1'24 | $156,000 | -83.9% | -396.8% | -10,000.0% | -$32.8M |
| Q4'23 | $4.1M | +156.1% | -636.5% | -1,152.9% | -$43.3M |
Company Information
Symbol
CLDX
Company
Celldex Therapeutics Inc
Market Cap
$3.24B